SeaStar Medical Files 8-K
Ticker: ICUCW · Form: 8-K · Filed: Sep 24, 2025 · CIK: 1831868
| Field | Detail |
|---|---|
| Company | Seastar Medical Holding CORP (ICUCW) |
| Form Type | 8-K |
| Filed Date | Sep 24, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, regulatory-filing
TL;DR
SeaStar Medical filed an 8-K on 9/24/25. Check for updates.
AI Summary
SeaStar Medical Holding Corp. filed an 8-K on September 24, 2025, reporting other events and financial statements. The company, formerly known as LMF Acquisition Opportunities Inc., is incorporated in Delaware and operates in the surgical and medical instruments sector.
Why It Matters
This filing indicates that SeaStar Medical Holding Corp. has made a regulatory submission, which could contain important updates for investors regarding the company's operations or financial status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports significant events but doesn't inherently signal high risk without further details.
Key Players & Entities
- SeaStar Medical Holding Corp (company) — Registrant
- LMF Acquisition Opportunities Inc (company) — Former company name
- September 24, 2025 (date) — Date of report
- 3841 (sic_code) — Standard Industrial Classification for Surgical & Medical Instruments & Apparatus
FAQ
What specific 'Other Events' are being reported by SeaStar Medical Holding Corp. in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the provided text snippet.
When was SeaStar Medical Holding Corp. formerly known as LMF Acquisition Opportunities Inc.?
The date of the name change from LMF Acquisition Opportunities Inc. to SeaStar Medical Holding Corporation was November 9, 2020.
What is the principal executive office address for SeaStar Medical Holding Corp.?
The principal executive offices are located at 3513 Brighton Blvd, Suite 410, Denver, Colorado, 80216.
Under which section of the Securities Exchange Act of 1934 is this 8-K report filed?
This 8-K report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the Standard Industrial Classification (SIC) code for SeaStar Medical Holding Corp.?
The SIC code for SeaStar Medical Holding Corp. is 3841, which corresponds to 'Surgical & Medical Instruments & Apparatus'.
Filing Stats: 499 words · 2 min read · ~2 pages · Grade level 13.5 · Accepted 2025-09-24 17:00:28
Key Financial Figures
- $0.0001 — ich registered Common Stock par value $0.0001 per share ICU The Nasdaq Stock Mark
- $11.50 — sable for one share of Common Stock for $11.50 per share ICUCW The Nasdaq Stock Ma
Filing Documents
- icu-20250924.htm (8-K) — 51KB
- icu-ex99_1.htm (EX-99.1) — 35KB
- img257978346_0.jpg (GRAPHIC) — 21KB
- 0001193125-25-215608.txt ( ) — 260KB
- icu-20250924.xsd (EX-101.SCH) — 45KB
- icu-20250924_htm.xml (XML) — 6KB
01 Other Events
Item 8.01 Other Events On September 24, 2025, SeaStar Medical Holding Corp. (the "Company"), issued a press release announcing that the independent Data Safety Monitoring Review Board (the "DSMB") has recommended the continuation of the NEUTRALIZE-AKI pivotal trial of the Selective Cytopheretic Device ("SCD") therapy in adult patients with acute kidney injury ("AKI") requiring continuous renal replacement therapy ("CRRT"). The DSMB notes that there were zero device-related safety issues. It also recommended an increase in the total patient enrollment in the trial to 339 patients to meet the original powering assumptions of the statistical analysis plan for the trial.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated September 24, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SeaStar Medical Holding Corporation By: /s/ Eric Schlorff Date: September 24, 2025 Name: Eric Schlorff Title: Chief Executive Officer